Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA055380 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA055380, RRID:AB_2682800
- Product name
- Anti-IFIT1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human IFIT1, Gene description: interferon-induced protein with tetratricopeptide repeats 1, Alternative Gene Names: G10P1, GARG-16, IFI56, IFNAI1, Validated applications: ICC, IHC, Uniprot ID: P09914, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus
IDO1+ Paneth cells promote immune escape of colorectal cancer
Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt/β-catenin signaling confers anti-apoptotic properties to colorectal cancer cells
Mähönen K, Hau A, Bondet V, Duffy D, Eklund K, Panelius J, Ranki A
Acta Dermato-Venereologica 2022;102
Acta Dermato-Venereologica 2022;102
IDO1+ Paneth cells promote immune escape of colorectal cancer
Pflügler S, Svinka J, Scharf I, Crncec I, Filipits M, Charoentong P, Tschurtschenthaler M, Kenner L, Awad M, Stift J, Schernthanner M, Bischl R, Herndler-Brandstetter D, Glitzner E, Moll H, Casanova E, Timelthaler G, Sibilia M, Gnant M, Lax S, Thaler J, Müller M, Strobl B, Mohr T, Kaser A, Trajanoski Z, Heller G, Eferl R
Communications Biology 2020;3(1)
Communications Biology 2020;3(1)
Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt/β-catenin signaling confers anti-apoptotic properties to colorectal cancer cells
Ohsugi T, Yamaguchi K, Zhu C, Ikenoue T, Furukawa Y
Oncotarget 2017;8(59):100176-100186
Oncotarget 2017;8(59):100176-100186
No comments: Submit comment
No validations: Submit validation data